SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.060
+0.010 (0.33%)
At close: Jun 6, 2025, 4:00 PM
3.250
+0.190 (6.21%)
After-hours: Jun 6, 2025, 7:14 PM EDT
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $209.15 million as of June 6, 2025. Its market cap has decreased by -31.05% in one year.
Market Cap
209.15M
Enterprise Value
170.75M
1-Year Change
-31.05%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $209.15M, a decrease of -81.33%. That is a compound annual growth rate of -35.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 6, 2025 | 209.15M | 2.54% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 691.79B |
| Johnson & Johnson | 372.58B |
| AbbVie | 335.86B |
| Novo Nordisk | 332.47B |
| UnitedHealth Group | 275.82B |
| Abbott Laboratories | 232.23B |
| Novartis AG | 230.96B |
| AstraZeneca | 226.14B |